Correlation of Serum Anti-Mullerian Hormone with Ovarian Follicle Output Rate in Infertile Females: A Clomiphene Citrate Challenge Test
Open Access
- 8 May 2020
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 12 (5) , e8032
Abstract
Failure to achieve a successful pregnancy after 12 months of unprotected intercourse is a pathology of the reproductive system known as infertility. Anti-Mullerian hormone (AMH) not only reflects the ovarian reserve but also is known to be a predictor of several assisted reproductive techniques, e.g., in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and clomiphene citrate challenge test. In this study, AMH levels are correlated with the follicular output rate after the clomiphene citrate challenge test. The objective of this study is to correlate AMH with the follicular output rate (FORT) after the clomiphene citrate challenge test. This study included a total of 80 primary and secondary infertile females, divided into early (18-30) and late (31-45) reproductive age groups either currently under clomiphene citrate treatment or advised to start clomiphene treatment, culled from out-patient department and centers of assisted reproductive techniques. On the third day of the menstrual cycle, blood samples were taken to determine serum AMH levels by ELISA. Then on the fifth day of the menstrual cycle, antral follicular counts were calculated through transvaginal ultrasound and oral tablet clomiphene citrate was started, and on day 12 and then on day 5, transvaginal ultrasound was repeated to record the number and diameter of dominant follicles. The pre-ovulatory (mature) follicle count was divided by the antral follicle count ×100 for calculating the FORT, which showed a negative Spearman Rho correlation (p = 0.048) with AMH. P-value ≤ 0.05 was considered significant. It is concluded that the most commonly administered drug, clomiphene citrate, may not be the treatment of choice for patients with high levels of AMH and may, in fact, interfere with the chances of achieving pregnancy. This study can provide guidelines to clinicians for patient counseling, given the results of the clomiphene citrate challenge test on the basis of AMH levels.Keywords
This publication has 20 references indexed in Scilit:
- Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessmentJournal of Endocrinological Investigation, 2016
- Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcomeHuman Reproduction, 2012
- Letrozole or clomiphene citrate as first line for anovulatory infertility: a debateReproductive Biology and Endocrinology, 2011
- Ovarian reserve testsJournal of Human Reproductive Sciences, 2011
- Serum anti-Mullerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulationHuman Reproduction, 2010
- Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissueHuman Reproduction, 2008
- Serum Anti-Müllerian Hormone Levels Reflect the Size of the Primordial Follicle Pool in MiceEndocrinology, 2006
- Anti-Müllerian hormone: a new marker for ovarian functionReproduction, 2006
- Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: A meta-analysis and comparison with basal follicle-stimulating hormone levelFertility and Sterility, 2005
- Intercycle variability of ovarian reserve tests: results of a prospective randomized studyHuman Reproduction, 2004